[COPD的药物管理]
Marina Gueçamburu1, Maeva Zysman2
1Service des maladies respiratoires, CHU Bordeaux, France.
La Revue du praticien
|February 8, 2024
概括
慢性阻塞性肺病 (COPD) 的管理涉及吸入疗法,如长效支气管扩展剂 (LABA/LAMA),并考虑生物标志物进行个性化治疗. 吸入性皮质类固醇 (ICS) 的降级对于COPD药物管理也至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 管理依赖于药理和非药理干预措施.
- 吸入疗法是核心的,解决像呼吸障碍和恶化等症状.
研究的目的:
- 概述COPD目前的药物管理策略.
- 讨论治疗升级和降级协议.
- 突出生物标志物和生物疗法在个性化COPD治疗中的作用.
主要方法:
- 审查目前的COPD临床指南和治疗方法.
- 吸入药物类别的讨论:短效和长效支气管扩展剂 (SABA,LABA,LAMA).
- 考虑组合疗法 (双重和三重疗法) 和吸入性皮质类固醇 (ICS) 的降级.
主要成果:
- 最初的治疗包括短效支气管扩展剂,以缓解症状.
- 每天的症状或恶化需要长效支气管扩展剂 (LABA或LAMA).
- 如果初始治疗不足,则应升级到双重或三重治疗.
- 吸入性皮质类固醇 (ICS) 的降级对于管理副作用或无效性至关重要.
- 生物标志物,如血中乙酸蛋白,对于指导治疗和识别生物疗法候选者的重要性越来越大.
结论:
- 慢性肺炎药物管理是一种逐步的方法,优先考虑支气管扩张,并根据患者表型考虑ICS.
- 治疗升级和降级是关键组成部分,以症状控制,恶化频率和副作用概况为指导.
- 生物标志物和新兴生物疗法的整合为在特定的COPD患者亚组中提供了量身定制的治疗策略的潜力.
更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:23Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442